| 来源类型 | Book |
| 规范类型 | 其他 |
| Health Care Matters: Pharmaceuticals, Obesity, and the Quality of Life | |
| H.E. Frech; Richard D. Miller Jr. | |
| 发表日期 | 2004-03-14 |
| 出版者 | AEI Press |
| 出版年 | 2004 |
| 语种 | 英语 |
| 摘要 | Read the full PDF. Buy the book. For many years, health policy in developed countries has rested on the assumption that health care consumption does relatively little to produce better health. This new study shows that it is time to rethink conventional wisdom, particularly regarding consumption of pharmaceuticals. In this sequel to their 1999 book, “The Productivity of Health Care and Pharmaceuticals: An International Comparison,” Richard D. Miller Jr. and H. E. Frech III extend their analysis to quality of life, disease-specific life expectancy, and the impact of obesity. This is possible because of newly available data from the World Health Organization and the Organisation for Economic Co-operation and Development (OECD) on disability-adjusted life expectancy, obesity, and disease-specific death rates. Employing a logical econometric model, Miller and Frech focus on 18 member countries of the OECD. They find that pharmaceutical consumption is even more powerful in improving the quality of life than in improving the length of life. They find variation by cause of death and by age. For individuals under 70, pharmaceutical consumption lowers circulatory disease mortality but has little effect on mortality due to either cancer or respiratory disease. At later ages, pharmaceutical consumption generally has a stronger impact. The fact that pharmaceutical consumption produces better health lends support to proposals to increase coverage of drugs in both public and private health insurance systems. Most fundamentally, it shows that policy should no longer be based on the assumption that health care consumption does not improve health, but rather on a new understanding that such consumption — especially pharmaceutical use — does matter. Richard D. Miller Jr. is a senior research analyst at the Institute for Public Research within the CNA Corporation in Alexandria, Virginia. He has also worked as an economist for the Bureau of Labor Statistics in Washington, DC. H. E. Frech III is professor of economics at the University of California, Santa Barbara, and an adjunct professor at Sciences Po in Paris. He has also been an economist in the predecessor of the US Department of Health and Human Services. |
| 主题 | Health Care |
| 标签 | AEI Archive ; AEI Press ; education ; Health care policy ; obesity ; Pharmaceuticals |
| URL | https://www.aei.org/research-products/book/health-care-matters/ |
| 来源智库 | American Enterprise Institute (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/208651 |
| 推荐引用方式 GB/T 7714 | H.E. Frech,Richard D. Miller Jr.. Health Care Matters: Pharmaceuticals, Obesity, and the Quality of Life. 2004. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
